Search Results - "Hames, Megan"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer by Hames, Megan L, Chen, Heidi, Iams, Wade, Aston, Jonathan, Lovly, Christine M, Horn, Leora

    Published in Lung cancer (Amsterdam, Netherlands) (01-02-2016)
    “…Highlights • G12C, G12D, and G12V were the most frequent KRAS mutations identified. • G12C and G12D mutations were associated with shorter OS compared to G12V…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner by Beitelshees, Amber L, Johnson, Julie A, Hames, Megan L, Gong, Yan, Cooper-Dehoff, Rhonda M, Wu, Jun, Cresci, Sharon, Ma, Cynthia X, Pepine, Carl J, Province, Michael A, Spertus, John A, McLeod, Howard L

    Published in PloS one (10-12-2010)
    “…CYP19A1 encodes aromatase, the enzyme responsible for the conversion of androgens to estrogens, and may play a role in variation in outcomes among men and…”
    Get full text
    Journal Article
  4. 4

    Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism by Iams, Wade T, Hames, Megan L, Tsai, Judy P, Dahlman, Kimberly B, Talbott, Mahsa S, Richards, Kristy L, Reddy, Nishitha M

    Published in Experimental hematology (01-02-2015)
    “…As the use of lenalidomide expands, the poorly understood phenomenon of lenalidomide-induced thyroid abnormalities will increase. In this study, we compared…”
    Get full text
    Journal Article
  5. 5

    The Use of Genetic Markers to Identify Lung Cancer in Fine Needle Aspiration Samples by Gill, Rajbir K, Vazquez, Madeline F, Kramer, Arin, Hames, Megan, Zhang, Lijuan, Heselmeyer-Haddad, Kerstin, Ried, Thomas, Shilo, Konstantin, Henschke, Claudia, Yankelevitz, David, Jen, Jin

    Published in Clinical cancer research (15-11-2008)
    “…Purpose: We seek to establish a genetic test to identify lung cancer using cells obtained through computed tomography–guided fine needle aspiration (FNA)…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Thyroid Dysfunction in Patients with Diffuse Large B-Cell Lymphoma Receiving Lenalidomide May be Mediated By TNF-α by Iams, Wade T, Hames, Megan L, Tsai, Judy Peih-Ying P, Dahlman, Kimberly B, Talbott, Mahsa, Richards, Kristy L., Reddy, Nishitha M.

    Published in Blood (06-12-2014)
    “…Background: The use of lenalidomide is expanding to include patients with refractory or relapsed diffuse large B cell lymphoma (DLBCL). Lenalidomide is less…”
    Get full text
    Journal Article
  9. 9

    Thyroid dysfunction in patients with diffuse large B-cell lymphoma receiving lenalidomide is mediated by TNF-α by Iams, Wade T., Hames, Megan L., Tsai, Judy P., Dahlman, Kimberly B., Talbott, Mahsa S., Richards, Kristy L., Reddy, Nishitha M.

    Published in Experimental hematology (28-10-2014)
    “…As the use of lenalidomide expands, the poorly understood phenomenon of lenalidomide-induced thyroid abnormalities will increase. In this study we compared…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Inactivation of LLC1 gene in nonsmall cell lung cancer by Hong, Kyeong‐Man, Yang, Sei‐Hoon, Chowdhuri, Sinchita Roy, Player, Audrey, Hames, Megan, Fukuoka, Junya, Meerzaman, Daoud, Dracheva, Tatiana, Sun, Zhifu, Yang, Ping, Jen, Jin

    Published in International journal of cancer (01-06-2007)
    “…Serial analysis of gene expression studies led us to identify a previously unknown gene, c20orf85, that is present in the normal lung epithelium but absent or…”
    Get full text
    Journal Article
  12. 12
  13. 13